Patents by Inventor Christiane Cantin

Christiane Cantin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR MODULATING TUMOR CELL ACTIVITY
    Publication number: 20150111250
    Abstract: Antibodies which target clusterin, a protein involved in the epithelial-to-mesenchymal transition of carcinoma cells, are identified and characterized. The antibodies may be used to modulate tumour cell activity through binding to clusterin.
    Type: Application
    Filed: September 24, 2014
    Publication date: April 23, 2015
    Inventors: Maureen O'Connor-McCourt, Christiane Cantin, Anne E.G. Lenferink
  • Methods and compositions for modulating tumor cell activity
    Patent number: 8426562
    Abstract: Antibodies which target clusterin, a protein involved in the epithelial-to-mesenchymal transition of carcinoma cells, are identified and characterized. The antibodies may be used to modulate tumor cell activity through binding the clusterin.
    Type: Grant
    Filed: July 29, 2010
    Date of Patent: April 23, 2013
    Assignee: National Research Council of Canada
    Inventors: Maureen D. O'Connor-McCourt, Christiane Cantin, Anne E. G. Lenferink
  • METHODS AND COMPOSITIONS FOR MODULATING TUMOR CELL ACTIVITY
    Publication number: 20120071635
    Abstract: Antibodies which target clusterin, a protein involved in the epithelial-to-mesenchymal transition of carcinoma cells, are identified and characterized. The antibodies may be used to modulate tumour cell activity through binding the clusterin.
    Type: Application
    Filed: October 7, 2011
    Publication date: March 22, 2012
    Applicant: National Research Council of Canada
    Inventors: Maureen D. O'Connor-McCourt, Christiane Cantin, Anne E.G. Lenferink
  • Methods and compositions for modulating tumor cell activity
    Patent number: 8044179
    Abstract: Antibodies which target clusterin, a protein involved in the epithelial-to-mesenchymal transition of carcinoma cells, are identified and characterized. The antibodies may be used to modulate tumour cell activity through binding to clusterin.
    Type: Grant
    Filed: September 13, 2006
    Date of Patent: October 25, 2011
    Inventors: Maureen D. O'Connor-McCourt, Christiane Cantin, Anne E. G. Lenferink
  • METHODS AND COMPOSITIONS FOR MODULATING TUMOR CELL ACTIVITY
    Publication number: 20110033471
    Abstract: Antibodies which target clusterin, a protein involved in the epithelial-to-mesenchymal transition of carcinoma cells, are identified and characterized. The antibodies may be used to modulate tumour cell activity through binding the clusterin.
    Type: Application
    Filed: July 29, 2010
    Publication date: February 10, 2011
    Applicant: NATIONAL RESEARCH COUNCIL OF CANADA
    Inventors: Maureen D. O'Connor-McCourt, Christiane Cantin, Anne E.G. Lenferink
  • Methods and compositions for modulating tumor cell activity
    Publication number: 20090104215
    Abstract: Antibodies which target clusterin, a protein involved in the epithelial-to-mesenchymal transition of carcinoma cells, are identified and characterized. The antibodies may be used to modulate tumour cell activity through binding to clusterin.
    Type: Application
    Filed: September 13, 2006
    Publication date: April 23, 2009
    Inventors: Irena Ekiel, Maureen D. O'Connor-McCourt, Christiane Cantin, Anne E.G. Lenferink